Menu

James Mackay is tending to 'unfinished business' with new gout biotech and $205M fundraise

Article |

nanorunner38 2mo ago
James Mackay is tending to 'unfinished business' with new gout biotech and $205M fundraise

Crystalys and its team of 10 people—and growing—is pushing ahead in hopes of filling the treatment gap for patients with gout.

Comments (0)

Newest

No comments yet.